Uncontrolled thrombocytosis in polycythemia vera is a risk for thrombosis, regardless of JAK2V617F mutational status

被引：7
|
作者：
Ohyashiki, K. [1 ]
Akahane, D.
Gotoh, A.
Ito, Y.
Tauchi, T.
Miyazawa, K.
Kimura, Y.
Ohyashiki, J. H.
机构：
[1] Tokyo Med Univ, Dept Internal Med 1, Div Hematol, Tokyo, Japan
[2] Tokyo Med Univ, Intractable Immune Syst Dis Res Ctr, Tokyo, Japan
来源：
LEUKEMIA | 2007年 / 21卷 / 12期
关键词：
D O I：
10.1038/sj.leu.2404829
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2544 / 2545
页数：3
相关论文
共 50 条
  • [41] JAK2V617F mutational load in patients with Polycythemia Vera (PV) measured by peripheral blood DNA is associated with disease severity
    Silver, Richard T.
    Vandris, Katherine
    Wang, Y. Lynn
    Christos, Paul J.
    Adriano, Fernando
    Jones, Amy V.
    Cross, Nicholas C. P.
    BLOOD, 2007, 110 (11) : 746A - 746A
  • [42] Prospective identification of high-risk polycythemia vera patients based on JAK2V617F allele burden
    Vannucchi, A. M.
    Antonioli, E.
    Guglielmelli, P.
    Longo, G.
    Pancrazzi, A.
    Ponziani, V.
    Bogani, C.
    Ferrini, P. Rossi
    Rambaldi, A.
    Guerini, V.
    Bosi, A.
    Barbui, T.
    LEUKEMIA, 2007, 21 (09) : 1952 - 1959
  • [43] EVALUATION OF THE CORRELATION BETWEEN JAK2V617F, LEUCOCYTOSIS AND THROMBOGENIC RISK IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA
    Antonov, Antonio
    Gercheva, Liana
    Stefanova, Nadezhda
    Tzaneva, Maria
    Chervenkov, Trifon
    JOURNAL OF IMAB, 2018, 24 (03): : 2085 - 2090
  • [44] Depletion of Jak2V617F MPN Stem Cells by IFNα in a Murine Model of Polycythemia Vera
    Mullally, Ann
    Bruedigam, Claudia
    Heckl, Dirk
    Poveromo, Luke
    Heidel, Florian H.
    Hill, Geoff
    Ebert, Benjamin L.
    Lane, Steven W.
    BLOOD, 2012, 120 (21)
  • [45] Cytogenetic studies at diagnosis in polycythemia vera:: Clinical and JAK2V617F allele burden correlates
    Gangat, Naseerna
    Strand, Jacob J.
    Lasho, Terra L.
    Finke, Christy M.
    Knudson, Ryan A.
    Pardanani, Animesh
    Li, Chin-Yang
    Ketterling, Rhett P.
    Tefferi, Ayalew
    BLOOD, 2007, 110 (11) : 750A - 750A
  • [46] POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA: JAK2V617F MUTATION IS MORE COMMON IN OLDER PATIENTS
    Randi, M. L.
    Ruzzon, E.
    Scapin, M.
    Tezza, E.
    Bertozzi, I.
    Fabris, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 60 - 60
  • [47] DIAGNOSTIC ACCURACY OF SERUM EPO LEVEL AND JAK2V617F ALLELE BURDEN IN POLYCYTHEMIA VERA
    Ancochea, A.
    Alvarez-Larran, A.
    Morales, C.
    Martinez-Aviles, L.
    Angona, A.
    Senin, A.
    Bellosillo, B.
    Besses, C.
    HAEMATOLOGICA, 2014, 99 : 391 - 392
  • [48] The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera
    Tefferi, A
    Lasho, TL
    Schwager, SM
    Strand, JS
    Elliott, M
    Mesa, R
    Li, CY
    Wadleigh, M
    Lee, SJ
    Gilliland, DG
    CANCER, 2006, 106 (03) : 631 - 635
  • [49] Prospective identification of high-risk polycythemia vera patients based on JAK2V617F allele burden
    A M Vannucchi
    E Antonioli
    P Guglielmelli
    G Longo
    A Pancrazzi
    V Ponziani
    C Bogani
    P R Ferrini
    A Rambaldi
    V Guerini
    A Bosi
    T Barbui
    Leukemia, 2007, 21 : 1952 - 1959
  • [50] Sigmoid Venous Thrombosis in JAK2 V617F Mutated Polycythemia Vera
    De Oliveira Filho, Cilomar Martins
    Gavralidis, Alexander
    CASE REPORTS IN HEMATOLOGY, 2022, 2022
12345